1. Impact of periprocedural myocardial necrosis on short term clinical outcome
- Author
-
Amr Elhadidy, Mahmoud Khaled, Yosef Haggag, and Mohamed Saleh
- Subjects
Acute coronary syndrome ,medicine.medical_specialty ,MACENTRODUCTION ,Cardiac biomarkers ,030204 cardiovascular system & hematology ,Critical Care and Intensive Care Medicine ,Outcome (game theory) ,03 medical and health sciences ,0302 clinical medicine ,Modified Gensini score ,Internal medicine ,Medicine ,Myocardial infarction ,Intensive care medicine ,business.industry ,ST elevation ,lcsh:Medical emergencies. Critical care. Intensive care. First aid ,PCI ,lcsh:RC86-88.9 ,030229 sport sciences ,medicine.disease ,Term (time) ,Heart failure ,Conventional PCI ,Poster Presentation ,Cardiology ,Myocardial necrosis ,business ,Mace ,Periprocedural myocardial necrosis - Abstract
Background: No reliable data whether periprocedural myocardial necrosis (PPN) has same poor prognostic value as periprocedural myocardial infarction (PMI) or not. We aimed to assess the impact of PPN on short term clinical outcome. Methods: 100 patients admitted with non ST elevation acute coronary syndrome and underwent PCI were enrolled. Patients were grouped according to the occurrence of PPN into 2 groups, and were followed for 3 months. Patients with PMI were excluded. Results: 30 patients (30%) had PPN and were associated with higher risks of major adverse cardiac events (MACE) during the hospital and 3 months follow up (43.3% and 66.7% vs. 12.9% and 14.3% respectively; p
- Published
- 2015